• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Recombinant Human Fumarylacetoacetase (FAH)

ACP24019

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ACP24019 Target NameFAH
Target SynonymsFAHFumarylacetoacetase; FAA; EC 3.7.1.2; Beta-diketonase; Fumarylacetoacetate hydrolaseFormLyophilized powder
Expression SystemCustom Production. Please inquire and provide the desire expression system.Expression Range2-419
Protein LengthFull Length of Mature ProteinPurity>85% (SDS-PAGE)
Storage Buffer5%-50% glycerol. Lyophilized powder form: the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, Liquid form: default storage buffer is Tris/PBS-based buffer, pH 8.0.

Immunogen Information


Target SpeciesHumanUniprot IDP16930
Background Information
  • Uniprot Id

    P16930

  • Target Species

    Human

  • Target Name

    FAH

  • Target Full Name

    Fumarylacetoacetase

  • Target Involvement

    Tyrosinemia 1 (TYRSN1)

  • Target Protein Families

    FAH family

  • Target Tissue Specificity

    Mainly expressed in liver and kidney. Lower levels are also detected in many other tissues.

  • Target Synonyms

    FAHFumarylacetoacetase; FAA; EC 3.7.1.2; Beta-diketonase; Fumarylacetoacetate hydrolase

  • Target Background

    Predicted to enable fumarylacetoacetase activity. Predicted to be involved in L-phenylalanine catabolic process; homogentisate catabolic process; and tyrosine catabolic process. Predicted to act upstream of or within arginine catabolic process. Located in extracellular exosome. Implicated in tyrosinemia type I.

Inquire Recombinant Human Fumarylacetoacetase (FAH) Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification